<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Ticagrelor Achieves Greater Efficacy In Trial</title>
	<atom:link href="http://www.medicalfacts.eu/2009/10/astrazeneca-ticagrelor-achieves-greater-efficacy-in-trial/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.medicalfacts.eu/2009/10/astrazeneca-ticagrelor-achieves-greater-efficacy-in-trial/</link>
	<description>Medical News</description>
	<lastBuildDate>Wed, 04 Nov 2009 14:43:18 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Verheugt: prasugrel redt geen levens &#124; Medicalfacts</title>
		<link>http://www.medicalfacts.eu/2009/10/astrazeneca-ticagrelor-achieves-greater-efficacy-in-trial/comment-page-1/#comment-39</link>
		<dc:creator>Verheugt: prasugrel redt geen levens &#124; Medicalfacts</dc:creator>
		<pubDate>Sat, 17 Oct 2009 14:15:29 +0000</pubDate>
		<guid isPermaLink="false">http://www.medicalfacts.eu/?p=248#comment-39</guid>
		<description>[...] on October 14, 2009 &#150; 23:52No Comment     Verheugt wacht daarom liever op de lancering van ticagrelor.&#8220;In tegenstelling tot eerdere berichten, is het nieuwe middel prasugrel, ter preventie van [...]</description>
		<content:encoded><![CDATA[<p>[...] on October 14, 2009 &#8211; 23:52No Comment     Verheugt wacht daarom liever op de lancering van ticagrelor.&#8220;In tegenstelling tot eerdere berichten, is het nieuwe middel prasugrel, ter preventie van [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

